Senti BiosciencesSNTI
13F holders, Q2 2026 (June 30)1holders −15
0new positions
2sold out
$1.10avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Senti Biosciences Inc. (SNTI) in their 13F filings, down 15 from Q1 2026. 0 opened new positions and 2 sold out. The largest holder was NEA Management Company, LLC ($4.2M).
- Company
- Senti Biosciences Inc.
- CUSIP
- 81726A209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $22K |
All 13F filers, Q1 2026 → Q2 2026: 26,844 shares sold, net −26,844 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| NEA Management Company, LLC | 0.26% | No change | 3,775,615 | $4.2M |
"% of holder's portfolio" is SNTI's weight in each manager's 13F, not the share of Senti Biosciences Inc. the manager owns.